Showing 1 - 4 results of 4 for search 'Marica De Cicco', query time: 0.03s Refine Results
  1. 1
    Pediatric Solid Cancers: Dissecting the Tumor Microenvironment to Improve the Results of Clinical Immunotherapy

    Pediatric Solid Cancers: Dissecting the Tumor Microenvironment to Improve the Results of Clinical Immunotherapy by Cristina Belgiovine, Kristiana Mebelli, Alessandro Raffaele, Marica De Cicco, Jessica Rotella, Paolo Pedrazzoli, Marco Zecca, Giovanna Riccipetitoni, Patrizia Comoli

    Published 2024-03-01
    Get full text
    Article
  2. 2
    Detection of Genotype-Specific Antibody Responses to Glycoproteins B and H in Primary and Non-Primary Human Cytomegalovirus Infections by Peptide-Based ELISA

    Detection of Genotype-Specific Antibody Responses to Glycoproteins B and H in Primary and Non-Primary Human Cytomegalovirus Infections by Peptide-Based ELISA by Federica Zavaglio, Loretta Fiorina, Nicolás M. Suárez, Chiara Fornara, Marica De Cicco, Daniela Cirasola, Andrew J. Davison, Giuseppe Gerna, Daniele Lilleri

    Published 2021-03-01
    Get full text
    Article
  3. 3
    Long-lasting responses with chemotherapy followed by T-cell therapy in recurrent or metastatic EBV-related nasopharyngeal carcinoma

    Long-lasting responses with chemotherapy followed by T-cell therapy in recurrent or metastatic EBV-related nasopharyngeal carcinoma by Simona Secondino, Simona Secondino, Paolo Pedrazzoli, Paolo Pedrazzoli, Paolo Pedrazzoli, Sabrina Basso, Sabrina Basso, Paolo Bossi, Alba Bianco, Alba Bianco, Ilaria Imarisio, Ilaria Imarisio, Anna Pagani, Marica De Cicco, Marica De Cicco, Stella Muscianisi, Stella Muscianisi, Michela Casanova, Carlo Morosi, Cristiana Bergamini, Marco Benazzo, Marco Benazzo, Maria Cossu Rocca, Cesare Perotti, Fausto Baldanti, Fausto Baldanti, Marco Zecca, Lisa F. Licitra, Lisa F. Licitra, Patrizia Comoli, Patrizia Comoli, Patrizia Comoli

    Published 2023-07-01
    Get full text
    Article
  4. 4
    Preclinical Validation of an Advanced Therapy Medicinal Product Based on Cytotoxic T Lymphocytes Specific for Mutated Nucleophosmin (NPM1<sup>mut</sup>) for the Treatment of NPM1<sup>mut</sup>-Acute Myeloid Leukemia

    Preclinical Validation of an Advanced Therapy Medicinal Product Based on Cytotoxic T Lymphocytes Specific for Mutated Nucleophosmin (NPM1<sup>mut</sup>) for the Treatment of NPM1<s... by Marica De Cicco, Ivana Lagreca, Sabrina Basso, Patrizia Barozzi, Stella Muscianisi, Alba Bianco, Giovanni Riva, Sara Di Vincenzo, Chiara Pulvirenti, Davide Sapuppo, Mariangela Siciliano, Vittorio Rosti, Anna Candoni, Marco Zecca, Fabio Forghieri, Mario Luppi, Patrizia Comoli

    Published 2023-05-01
    Get full text
    Article

Search Tools: